Multiple sclerosis (MS) is a chronic demyelinating disease of the central nervous system that occurs primarily in young adults. The prognosis of the ocular manifestations of multiple sclerosis will depend on the establishment of timely treatment, both for the systemic disease and its relapses, the severity of the involvement and recurrence of ocular syndromic episodes. However, the presence of some ocular effects secondary to treatment has been demonstrated in patients with MS. These findings can be difficult to distinguish and treat. The objective is to carry out a review of the literature on the ocular adverse effects of drug treatment in patients with multiple sclerosis.
|Effective start/end date
|6/12/19 → 6/30/20
UN Sustainable Development Goals
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This project contributes towards the following SDG(s):
Main Funding Source
- Installed Capacity (Academic Unit)
- Bogotá D.C.
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.